Lavo Life Sciences
Lavo Life Sciences provides AI-accelerated crystal structure prediction for small molecule drugs, aiming to de-risk drug development pipelines, optimize solid-state formulations, and avoid late-stage surprises. Their core offering is Crystal Console, a web-based platform featuring structure analysis, virtual polymorph screening, and PXRD analysis. They also offer contract research services for dedicated crystallography support. The company's technology leverages AI-powered predictions and deep scientific expertise to offer fast, efficient, and insightful solutions, enabling optimization of formulations, discovery of novel polymorphs, acceleration of development timelines, and enhancement of decision-making in pharmaceutical research and development.
Lavo Life Sciences
Lavo Life Sciences provides AI-accelerated crystal structure prediction for small molecule drugs, aiming to de-risk drug development pipelines, optimize solid-state formulations, and avoid late-stage surprises. Their core offering is Crystal Console, a web-based platform featuring structure analysis, virtual polymorph screening, and PXRD analysis. They also offer contract research services for dedicated crystallography support. The company's technology leverages AI-powered predictions and deep scientific expertise to offer fast, efficient, and insightful solutions, enabling optimization of formulations, discovery of novel polymorphs, acceleration of development timelines, and enhancement of decision-making in pharmaceutical research and development.
TL;DR
What they do: AI-accelerated crystal structure prediction and polymorph screening for small-molecule drug development
Flagship product: Crystal Console — web platform for prediction, analysis, PXRD support and 3D visualization
Founded: 2022
Headcount (reported): 3 employees
Reported investors: BBQ Capital, Eastlink Capital, Y Combinator
Company Overview
Problem Domain
Solid-state characterization and polymorph risk in small-molecule drug development
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
500000
Investor Signal
“BBQ Capital, Eastlink Capital, Y Combinator”